Peyton R Howell insider trades

Open-market stock purchases and sales by Peyton R Howell, Director at Tandem Diabetes Care Inc, from SEC Form 4 filings since Feb 20, 2012.

Track record: 0% of 6 scored buys are up 5% or more since purchase, averaging -62%.

Recent trades

DateStockTradeValue
May 21, 2026TNDM Tandem Diabetes Care IncBought (not open market)—
May 20, 2026TNDM Tandem Diabetes Care IncBought (not open market)—

Companies traded

  • TNDM Tandem Diabetes Care Inc: 6 buys, last May 21, 2026
  • ABC Amerisourcebergen Corp: 23 sales, last Apr 4, 2018

Get free alerts when Peyton R Howell files a new trade →